UnitedHealth Leads Health Insurance Stocks in Market Decline

UnitedHealth Group's stock fell for the second consecutive day following the murder of its CEO, Brian Thompson, and growing backlash against the company's insurance practices, particularly its high claim denial rate. Despite some analysts raising their price targets based on the company's 2025 earnings guidance, investor sentiment was negatively impacted by public outrage and potential ESG concerns. The situation has drawn national attention, with calls for regulatory changes and possible divestment from health insurance stocks.